• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: May 2018

Animal Health

The secret to longevity is in the microbiome and the gut

May 31, 2018 Microbiome Times

You are what you eat. Or so the saying goes. Science now tells us that we are what the bacteria living in our intestinal tract eat and this could have an influence on how well […]

Animal Health

Microbiome Insights, Global Leader in Microbiome Testing, Expands to New Lab Facilities on UBC Campus

May 31, 2018 Microbiome Times

Microbiome Insights, Inc. has announced the opening of its new laboratory on the campus of the University of British Columbia (UBC). The company, a leading end-to-end service provider for microbiome DNA sequencing and bioinformatic analysis, […]

Pharma & Human Health

Realm Therapeutics Completes Enrollment in Phase 2 Study of PR022 for Atopic Dermatitis

May 25, 2018 Microbiome Times

Realm Therapeutics plc (AIM:RLM), a clinical stage biopharmaceutical company focused on developing novel therapeutics in immune-mediated diseases, today announces that the Company has completed enrollment in its Phase 2 study of PR022, Realm’s first-in-class topical […]

Pharma & Human Health

Project PROMISE for Clinical Research and Treatment of Metabolic Syndrome

May 25, 2018 Microbiome Times

The kick-off meeting of the Eurostars-funded PROMISE project, a collaboration between Caelus Health and BaseClear from The Netherlands, ProDigest from Belgium and IBBL from Luxemburg, was held on the 7th of May. The aim of […]

Pharma & Human Health

Brazilian Health Authorities Recognize Bifidobacterium Lactis HN019™ as Beneficial to Gastrointestinal Health

May 25, 2018 Microbiome Times

DuPont Nutrition & Health today announced it has received approval from the Brazilian Health Regulatory Agency (ANVISA) recognizing a health claim for the Bifidobacterium lactis HN019™ probiotic strain. Customers in Brazil can now bring new […]

Pharma & Human Health

Oragenics, Inc. and Texas A&M University System Granted U.S. Patent for Lantibiotic MU1140

May 24, 2018 Microbiome Times

Oragenics, Inc. (NYSE American: OGEN) (the “Company”), a clinical stage biotechnology company, today announced that the United States Patent and Trademark Office (USPTO) has granted Oragenics and The Texas A&M University System U.S. Patent No. […]

Finance

Management Changes at BioGaia

May 24, 2018 Microbiome Times

Axel Sjöblad was appointed as Managing Director effective March 1, 2016 and has successfully focused on further expanding BioGaias sales capabilities. ”I am proud of the progress that has taken place at the company during […]

Pharma & Human Health

Monotherapy Trial Approved; the First Live Biotherapeutic Trial in Cancer

May 21, 2018 Microbiome Times

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced that the Company has submitted, and the Medicines and Healthcare products Regulatory Agency (MHRA) has cleared, a Clinical Trial […]

Finance

Scioto Biosciences Closes $1.8M in Series A Financing

May 21, 2018 Microbiome Times

Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed on $1.8M in Series A financing to support the launch of its new microbiome […]

Pharma & Human Health

New AZO Product Restores and Protects Vaginal Health

May 17, 2018 Microbiome Times

Most women will experience the discomfort that accompanies vaginal imbalance at some point in their lives. Everyday activities and stressors, from sex to tight clothing or even diet and medication, can all disrupt vaginal health. […]

Pharma & Human Health

Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children

May 17, 2018 Microbiome Times

Merck announced a collaboration with Washington University in St. Louis, Missouri, USA, that could lead to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome). The two-year collaboration will employ Merck’s […]

Posts navigation

1 2 3 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
  • Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
    April 3, 2025
  • Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
    March 25, 2025
  • Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
    March 5, 2025
sign up

Sign up to the Microbiome Times newsletter